Pre-made Erenumab benchmark antibody ( Whole mAb, anti-CALCRL/CGRPR therapeutic antibody, Anti-CRLR/LMPHM8 Antibody) for drug discovery and mechanism of action (MOA) researchCat No.: GMP-Bios-ab-193
Pre-Made Erenumab biosimilar, Whole mAb, Anti-CALCRL/CGRPR Antibody: Anti-CRLR/LMPHM8 therapeutic antibody is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Erenumab, sold under the brand name Aimovig, is a medication which targets the calcitonin gene-related peptide receptor (CGRPR) for the prevention of migraine.
* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry
|Catalog No.||Package||List Price(In USD)||Discount off||Discount Price|
Size： 1mg | 10mg | 100mg
|Products Name (INN Index)||Pre-Made Erenumab biosimilar, Whole mAb, Anti-CALCRL/CGRPR Antibody: Anti-CRLR/LMPHM8 therapeutic antibody|
|Highest_Clin_Trial (Jan '20)||Approved|
|100% SI Structure||6umh:HL/6umi:HL/6umj:HL|
|99% SI Structure||None|
|95-98% SI Structure||None|
|Conditions Discontinued||Hot flushes|
|Development Tech||Abgenix XenoMouse|